human il 12 p70 Search Results


95
R&D Systems human il 12 p70
Human Il 12 P70, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+il+12+p70/Human+IL-12+p70+Quantikine+ELISA+Kit/pm12594246-41-44-54
Average 95 stars, based on 1 article reviews
human il 12 p70 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

95
R&D Systems il 12p70
Il 12p70, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+il+12+p70/Human+IL-12+p70+DuoSet+ELISA/pm34183371-102-21-22
Average 95 stars, based on 1 article reviews
il 12p70 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

93
R&D Systems il 12 p70
Il 12 P70, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+il+12+p70/Human+IL-12+p70+XL+Luminex%C2%AE+Performance+Assay/pm38407518-60-52-99
Average 93 stars, based on 1 article reviews
il 12 p70 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
MedChemExpress il 12
Il 12, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+il+12+p70/IL-12%2C+Human/pmc12364008-24-18-21
Average 93 stars, based on 1 article reviews
il 12 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

91
R&D Systems il 12
Il 12, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+il+12+p70/Human+IL-12+p70+Quantikine+HS+ELISA+Kit/pm28968786-71-29-46
Average 91 stars, based on 1 article reviews
il 12 - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

94
R&D Systems anti human il12 p70
Anti Human Il12 P70, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+il+12+p70/Human+IL-12+p70+Antibody/pm41772660-46-25-29
Average 94 stars, based on 1 article reviews
anti human il12 p70 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
R&D Systems human il 12p70 antibody
Allogeneic MLRs were performed using moDCs and CD4 + T cells from healthy individuals. SEB was added in the presence or absence of ( a ) IL-1β and ( b ) neutralizing IL-1β antibodies, IL-1 receptor antagonist or appropriate isotype control. After 72 h, supernatants were assayed for IFNγ using an ELISA. Percentage inhibition values are calculated by considering the percent of cytokine secretion upon LPS stimulation alone (for IL-1RA) or LPS in combination with mouse IgG1 isotype (for anti- IL-1β) as 100%. ( c ) Allogeneic MLRs were performed using moDCs and CD4 + T cells from an IL10RA -deficient patient or healthy individuals in the presence of SEB with or without IL-1β. ( d, e ) Allogeneic MLRs were performed using moDCs and CD4 + T cells from healthy individuals. SEB was added in the presence or absence of ( d ) LPS, IL-1β and IL-10 or ( e ) LPS with or without neutralizing IL-12 antibodies or appropriate isotype control. After 72 h, supernatants were assayed for ( d ) <t>IL-12p70</t> and ( e ) IFNγ using an ELISA. ( f ) Adult healthy controls (n=4) and IL10RA -deficient patient moDCs were stimulated with LPS for 20 h and IL-12p70 was determined by ELISA. ( g ) CD4 + T cells from healthy controls (n=4) and an IL10RA -deficient patient (PT) were stimulated with anti-CD3/CD28 beads in the presence or absence of IL-1β. ( h ) Allogeneic MLRs were performed using moDCs and CD4 + T cells from an IL10RA -deficient patient or healthy individuals in the presence of SEB with or without IL-1β and IL-10. Results are mean ± SD (D-H) or mean ± SEM (B, C, G left) of a representative of at least two independent experiments. * P <0.05, ** P <0.01, *** P <0.001 using unpaired Student’s t test.
Human Il 12p70 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+il+12+p70/Human+IL-12+p70+Antibody/pmc06752724-174-129-134
Average 94 stars, based on 1 article reviews
human il 12p70 antibody - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Cusabio human interleukin 12
Allogeneic MLRs were performed using moDCs and CD4 + T cells from healthy individuals. SEB was added in the presence or absence of ( a ) IL-1β and ( b ) neutralizing IL-1β antibodies, IL-1 receptor antagonist or appropriate isotype control. After 72 h, supernatants were assayed for IFNγ using an ELISA. Percentage inhibition values are calculated by considering the percent of cytokine secretion upon LPS stimulation alone (for IL-1RA) or LPS in combination with mouse IgG1 isotype (for anti- IL-1β) as 100%. ( c ) Allogeneic MLRs were performed using moDCs and CD4 + T cells from an IL10RA -deficient patient or healthy individuals in the presence of SEB with or without IL-1β. ( d, e ) Allogeneic MLRs were performed using moDCs and CD4 + T cells from healthy individuals. SEB was added in the presence or absence of ( d ) LPS, IL-1β and IL-10 or ( e ) LPS with or without neutralizing IL-12 antibodies or appropriate isotype control. After 72 h, supernatants were assayed for ( d ) <t>IL-12p70</t> and ( e ) IFNγ using an ELISA. ( f ) Adult healthy controls (n=4) and IL10RA -deficient patient moDCs were stimulated with LPS for 20 h and IL-12p70 was determined by ELISA. ( g ) CD4 + T cells from healthy controls (n=4) and an IL10RA -deficient patient (PT) were stimulated with anti-CD3/CD28 beads in the presence or absence of IL-1β. ( h ) Allogeneic MLRs were performed using moDCs and CD4 + T cells from an IL10RA -deficient patient or healthy individuals in the presence of SEB with or without IL-1β and IL-10. Results are mean ± SD (D-H) or mean ± SEM (B, C, G left) of a representative of at least two independent experiments. * P <0.05, ** P <0.01, *** P <0.001 using unpaired Student’s t test.
Human Interleukin 12, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+il+12+p70/Human+Interleukin+12%2CIL-12%2FP70+ELISA+KIT/ppr0639964-46-0-9
Average 93 stars, based on 1 article reviews
human interleukin 12 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
R&D Systems human il 12 p70 duoset elisa
Allogeneic MLRs were performed using moDCs and CD4 + T cells from healthy individuals. SEB was added in the presence or absence of ( a ) IL-1β and ( b ) neutralizing IL-1β antibodies, IL-1 receptor antagonist or appropriate isotype control. After 72 h, supernatants were assayed for IFNγ using an ELISA. Percentage inhibition values are calculated by considering the percent of cytokine secretion upon LPS stimulation alone (for IL-1RA) or LPS in combination with mouse IgG1 isotype (for anti- IL-1β) as 100%. ( c ) Allogeneic MLRs were performed using moDCs and CD4 + T cells from an IL10RA -deficient patient or healthy individuals in the presence of SEB with or without IL-1β. ( d, e ) Allogeneic MLRs were performed using moDCs and CD4 + T cells from healthy individuals. SEB was added in the presence or absence of ( d ) LPS, IL-1β and IL-10 or ( e ) LPS with or without neutralizing IL-12 antibodies or appropriate isotype control. After 72 h, supernatants were assayed for ( d ) <t>IL-12p70</t> and ( e ) IFNγ using an ELISA. ( f ) Adult healthy controls (n=4) and IL10RA -deficient patient moDCs were stimulated with LPS for 20 h and IL-12p70 was determined by ELISA. ( g ) CD4 + T cells from healthy controls (n=4) and an IL10RA -deficient patient (PT) were stimulated with anti-CD3/CD28 beads in the presence or absence of IL-1β. ( h ) Allogeneic MLRs were performed using moDCs and CD4 + T cells from an IL10RA -deficient patient or healthy individuals in the presence of SEB with or without IL-1β and IL-10. Results are mean ± SD (D-H) or mean ± SEM (B, C, G left) of a representative of at least two independent experiments. * P <0.05, ** P <0.01, *** P <0.001 using unpaired Student’s t test.
Human Il 12 P70 Duoset Elisa, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+il+12+p70/Human+IL-12+p70+DuoSet+ELISA/pm37805067-300-12-17
Average 94 stars, based on 1 article reviews
human il 12 p70 duoset elisa - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
R&D Systems elisa
Allogeneic MLRs were performed using moDCs and CD4 + T cells from healthy individuals. SEB was added in the presence or absence of ( a ) IL-1β and ( b ) neutralizing IL-1β antibodies, IL-1 receptor antagonist or appropriate isotype control. After 72 h, supernatants were assayed for IFNγ using an ELISA. Percentage inhibition values are calculated by considering the percent of cytokine secretion upon LPS stimulation alone (for IL-1RA) or LPS in combination with mouse IgG1 isotype (for anti- IL-1β) as 100%. ( c ) Allogeneic MLRs were performed using moDCs and CD4 + T cells from an IL10RA -deficient patient or healthy individuals in the presence of SEB with or without IL-1β. ( d, e ) Allogeneic MLRs were performed using moDCs and CD4 + T cells from healthy individuals. SEB was added in the presence or absence of ( d ) LPS, IL-1β and IL-10 or ( e ) LPS with or without neutralizing IL-12 antibodies or appropriate isotype control. After 72 h, supernatants were assayed for ( d ) <t>IL-12p70</t> and ( e ) IFNγ using an ELISA. ( f ) Adult healthy controls (n=4) and IL10RA -deficient patient moDCs were stimulated with LPS for 20 h and IL-12p70 was determined by ELISA. ( g ) CD4 + T cells from healthy controls (n=4) and an IL10RA -deficient patient (PT) were stimulated with anti-CD3/CD28 beads in the presence or absence of IL-1β. ( h ) Allogeneic MLRs were performed using moDCs and CD4 + T cells from an IL10RA -deficient patient or healthy individuals in the presence of SEB with or without IL-1β and IL-10. Results are mean ± SD (D-H) or mean ± SEM (B, C, G left) of a representative of at least two independent experiments. * P <0.05, ** P <0.01, *** P <0.001 using unpaired Student’s t test.
Elisa, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+il+12+p70/Human+IL-12+p70+Quantikine+ELISA+Kit/pmc10970569-168-8-15
Average 94 stars, based on 1 article reviews
elisa - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Proteintech il 12p70
Allogeneic MLRs were performed using moDCs and CD4 + T cells from healthy individuals. SEB was added in the presence or absence of ( a ) IL-1β and ( b ) neutralizing IL-1β antibodies, IL-1 receptor antagonist or appropriate isotype control. After 72 h, supernatants were assayed for IFNγ using an ELISA. Percentage inhibition values are calculated by considering the percent of cytokine secretion upon LPS stimulation alone (for IL-1RA) or LPS in combination with mouse IgG1 isotype (for anti- IL-1β) as 100%. ( c ) Allogeneic MLRs were performed using moDCs and CD4 + T cells from an IL10RA -deficient patient or healthy individuals in the presence of SEB with or without IL-1β. ( d, e ) Allogeneic MLRs were performed using moDCs and CD4 + T cells from healthy individuals. SEB was added in the presence or absence of ( d ) LPS, IL-1β and IL-10 or ( e ) LPS with or without neutralizing IL-12 antibodies or appropriate isotype control. After 72 h, supernatants were assayed for ( d ) <t>IL-12p70</t> and ( e ) IFNγ using an ELISA. ( f ) Adult healthy controls (n=4) and IL10RA -deficient patient moDCs were stimulated with LPS for 20 h and IL-12p70 was determined by ELISA. ( g ) CD4 + T cells from healthy controls (n=4) and an IL10RA -deficient patient (PT) were stimulated with anti-CD3/CD28 beads in the presence or absence of IL-1β. ( h ) Allogeneic MLRs were performed using moDCs and CD4 + T cells from an IL10RA -deficient patient or healthy individuals in the presence of SEB with or without IL-1β and IL-10. Results are mean ± SD (D-H) or mean ± SEM (B, C, G left) of a representative of at least two independent experiments. * P <0.05, ** P <0.01, *** P <0.001 using unpaired Student’s t test.
Il 12p70, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+il+12+p70/Human+IL-12+p70+ELISA+Kit/pm41035003-97-4-20
Average 93 stars, based on 1 article reviews
il 12p70 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

Image Search Results


Allogeneic MLRs were performed using moDCs and CD4 + T cells from healthy individuals. SEB was added in the presence or absence of ( a ) IL-1β and ( b ) neutralizing IL-1β antibodies, IL-1 receptor antagonist or appropriate isotype control. After 72 h, supernatants were assayed for IFNγ using an ELISA. Percentage inhibition values are calculated by considering the percent of cytokine secretion upon LPS stimulation alone (for IL-1RA) or LPS in combination with mouse IgG1 isotype (for anti- IL-1β) as 100%. ( c ) Allogeneic MLRs were performed using moDCs and CD4 + T cells from an IL10RA -deficient patient or healthy individuals in the presence of SEB with or without IL-1β. ( d, e ) Allogeneic MLRs were performed using moDCs and CD4 + T cells from healthy individuals. SEB was added in the presence or absence of ( d ) LPS, IL-1β and IL-10 or ( e ) LPS with or without neutralizing IL-12 antibodies or appropriate isotype control. After 72 h, supernatants were assayed for ( d ) IL-12p70 and ( e ) IFNγ using an ELISA. ( f ) Adult healthy controls (n=4) and IL10RA -deficient patient moDCs were stimulated with LPS for 20 h and IL-12p70 was determined by ELISA. ( g ) CD4 + T cells from healthy controls (n=4) and an IL10RA -deficient patient (PT) were stimulated with anti-CD3/CD28 beads in the presence or absence of IL-1β. ( h ) Allogeneic MLRs were performed using moDCs and CD4 + T cells from an IL10RA -deficient patient or healthy individuals in the presence of SEB with or without IL-1β and IL-10. Results are mean ± SD (D-H) or mean ± SEM (B, C, G left) of a representative of at least two independent experiments. * P <0.05, ** P <0.01, *** P <0.001 using unpaired Student’s t test.

Journal: Mucosal immunology

Article Title: IL-10 signaling in dendritic cells controls IL-1β-mediated IFNγ secretion by human CD4 + T cells: relevance to inflammatory bowel disease

doi: 10.1038/s41385-019-0194-9

Figure Lengend Snippet: Allogeneic MLRs were performed using moDCs and CD4 + T cells from healthy individuals. SEB was added in the presence or absence of ( a ) IL-1β and ( b ) neutralizing IL-1β antibodies, IL-1 receptor antagonist or appropriate isotype control. After 72 h, supernatants were assayed for IFNγ using an ELISA. Percentage inhibition values are calculated by considering the percent of cytokine secretion upon LPS stimulation alone (for IL-1RA) or LPS in combination with mouse IgG1 isotype (for anti- IL-1β) as 100%. ( c ) Allogeneic MLRs were performed using moDCs and CD4 + T cells from an IL10RA -deficient patient or healthy individuals in the presence of SEB with or without IL-1β. ( d, e ) Allogeneic MLRs were performed using moDCs and CD4 + T cells from healthy individuals. SEB was added in the presence or absence of ( d ) LPS, IL-1β and IL-10 or ( e ) LPS with or without neutralizing IL-12 antibodies or appropriate isotype control. After 72 h, supernatants were assayed for ( d ) IL-12p70 and ( e ) IFNγ using an ELISA. ( f ) Adult healthy controls (n=4) and IL10RA -deficient patient moDCs were stimulated with LPS for 20 h and IL-12p70 was determined by ELISA. ( g ) CD4 + T cells from healthy controls (n=4) and an IL10RA -deficient patient (PT) were stimulated with anti-CD3/CD28 beads in the presence or absence of IL-1β. ( h ) Allogeneic MLRs were performed using moDCs and CD4 + T cells from an IL10RA -deficient patient or healthy individuals in the presence of SEB with or without IL-1β and IL-10. Results are mean ± SD (D-H) or mean ± SEM (B, C, G left) of a representative of at least two independent experiments. * P <0.05, ** P <0.01, *** P <0.001 using unpaired Student’s t test.

Article Snippet: Purified CD4 + T cells and moDCs were used either directly in stimulation assays or co-cultured as indicated in an allogeneic mixed lymphocyte reaction (MLR) for 72 h. The various cell populations were stimulated for the indicated time-points with: purified lipopolysaccharide from Escherichia coli Serotype 0111:B4 (100 ng/ml, Sigma-Aldrich, St. Louis, MO), adenosine 5’-triphosphate disodium salt (ATP, 5 mM, InvivoGen, San Diego, CA), soluble anti-CD3 antibody (500 ng/ml; Sanquin, the Netherlands), plate-bound anti-CD3 antibody (clone OKT3 – 0.1,1, 10 μg/ml, Biolegend, San Diego, CA), anti-CD3/CD28 beads (bead-to-cell ratio 1:2 or 1:4, Invitrogen), Staphylococcal enterotoxin B (SEB, 0.05 μg/ml, Sigma-Aldrich or List Biological laboratories Inc, Campbell, CA), IL-10 (25 ng/ml, R&D Systems), IL-1β (10 ng/ml, R&D Systems), neutralizing IL-1β antibodies (canakunimab, 10 μg/ml), IL-1 receptor antagonist (anakinra, 5 μg/ml), neutralizing human IL-12p70 antibody (10 μg/ml, R&D systems, Minneapolis, MN) or appropriate isotype controls.

Techniques: Control, Enzyme-linked Immunosorbent Assay, Inhibition